drugset / Trial / NCT03907657
Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
Phase 2
Completed
15 enrolled
UNC Lineberger Comprehensive Cancer Center
Lantheus Medical Imaging · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine if contrast-enhanced ultrasound can detect abnormal features of kidney lesions in patients with Von-Hippel Lindau with the same accuracy as conventional ultrasound and contrast-enhanced magnetic resonance imaging (MRI)
Timeline
- Start
- 2019-09-23
- Primary completion
- 2023-03-13
- Completion
- 2023-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Definity | Diagnostic / imaging agent | — | Intravenous |
| Subject | Lumason | Diagnostic / imaging agent | — | Intravenous |